Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07694414 |
| Title | Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events (RiTOX) |
| Acronym | RiTOX |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Inge Marie Svane |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DNK |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital | Herlev | Herlev | 2730 | Denmark | Details |